Today: 9 June 2026
NTPC share price rises as a ₹380 buy call lands, but MarketsMojo sticks to ‘Sell’
20 January 2026
2 mins read

NTPC share price rises as a ₹380 buy call lands, but MarketsMojo sticks to ‘Sell’

Mumbai, January 20, 2026, 11:39 IST

  • NTPC hovered between Rs 345 and 347 in late morning trade on Tuesday, following a stronger start to the session
  • A Mirae Asset Sharekhan strategist highlighted a buy range between Rs 342 and Rs 346, setting a target of Rs 380
  • MarketsMojo stuck with a ‘Sell’ rating, highlighting limited returns and elevated leverage ratios

Shares of NTPC Ltd nudged up in early Tuesday trading, hovering around Rs 345.05 by 11:24 a.m. IST, marking a roughly 0.5% gain for the day. The stock had earlier touched Rs 347.30, according to a live update from . By that time, roughly 3.39 million shares changed hands, and the price-to-earnings ratio stood at 14.15.

NTPC’s shifts carry weight, as it ranks among India’s largest listed utilities and is a staple in many portfolios for its defensive, dividend-driven appeal. When investors pivot to more stable large caps, stocks like this often attract quick follow-up buying.

NTPC faces a tug-of-war: short-term chart traders eyeing a breakout versus screens flagging ongoing balance-sheet stress. Each group has the power to drive the stock—and the potential to exit fast if key levels falter.

Somil Mehta, head of alternate research and capital market strategy at Mirae Asset Sharekhan, advised buying NTPC between Rs 342 and Rs 346, setting a stop loss at Rs 328 and aiming for Rs 380, the Times of India reported. He called it a “descending trendline breakout” and noted “momentum indicators are positive.” A stop loss here serves as a preset limit to cut losses, while moving averages help smooth out daily price fluctuations. The Times of India

MarketsMojo, which ranks stocks using its “Mojo Score,” kept NTPC at ‘Sell,’ with the last update on Nov. 10, 2025, when the score dropped from 55 to 42. The current report uses data through Jan. 20, 2026. It highlighted an average return on capital employed (ROCE) of 8.24% and a debt-to-EBITDA ratio of 4.81 times, while the technical outlook came in as mildly bearish. (ROCE measures profitability against capital, and debt-to-EBITDA compares debt levels to operating earnings.) Markets Mojo

The scale of NTPC works both for and against it. While its regulated status and size help stabilize cash flow, hefty expansion projects and older thermal plants may keep leverage high and returns limited—particularly if input costs rise or tariff regulations change.

In the power sector, investors often pit NTPC against peers like Tata Power and Torrent Power, each with their own blend of renewable and conventional assets. The debate tends to focus less on short-term price moves and more on execution and how much room they have on the balance sheet.

The chart trade can quickly reverse. Should the broader market shift or changes in policy and fuel-cost assumptions hit the sector, the stock may fall below support levels, pushing short-term buyers to sell off their positions.

NTPC jumped 3.43% earlier this month, hitting Rs 349.5 in one session, and then pushed higher for a third day running, Business Standard reported. Trading volume stood at 102.16 lakh shares, above the one-month daily average of 92.27 lakh.

NTPC currently balances between a trader’s bullish target and a screener’s caution flags on profitability and leverage. Investors will be focused on upcoming earnings, project updates, and any policy changes to gauge if returns can rise without taking on more debt.

++

Stock Market Today

  • Rocket Lab Stock Price Forecast: AI Analyst Cautions Despite 60% Surge
    June 9, 2026, 10:12 AM EDT. Shares of Rocket Lab USA ($RKLB) have jumped more than 60% year-to-date due to increased demand for small-satellite launches. Despite the rally, AI-driven analysis from TipRanks highlights caution, urging investors to consider potential market volatility and competitive pressures. Rocket Lab's growth taps into expanding satellite deployment, but risks remain in a crowded aerospace sector. Investors should balance optimism with these cautionary signals from advanced analytics.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
STMicroelectronics stock slides nearly 5% on Trump Greenland tariff threat; what to watch next
Previous Story

STMicroelectronics stock slides nearly 5% on Trump Greenland tariff threat; what to watch next

DBS share price dips after CGS downgrade, with Feb. 9 results the next test
Next Story

DBS share price dips after CGS downgrade, with Feb. 9 results the next test

Go toTop